Inverness Counsel LLC Cyto Dyn Inc. Transaction History

Inverness Counsel LLC

  • $1.8 Billion
  • Q3 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 20, 2022
SELL
$0.24 - $0.51 $2,400 - $5,100
-10,000 Closed
0 $0
Q1 2021

May 04, 2021
SELL
$2.12 - $7.15 $10,600 - $35,750
-5,000 Reduced 33.33%
10,000 $27,000
Q3 2017

Oct 17, 2017
BUY
$0.6 - $0.72 $9,000 - $10,800
15,000
15,000 $9,000

Others Institutions Holding CYDY

# of Institutions
8
Shares Held
244K
Call Options Held
0
Put Options Held
0
View Full List

About CytoDyn Inc.

CYDY Quotes by TradingView
  • Ticker CYDY
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 813,040,000
  • Market Cap $122M
  • Description
  • CytoDyn Inc. operates as a clinical-stage biotechnology company. The company focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor in the areas of human immunodeficiency virus (HIV), non-alcoholic steatohepatitis (NASH), oncology, and such as c...
More about CYDY
Track This Portfolio

Track Inverness Counsel LLC Portfolio

Follow Inverness Counsel LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inverness Counsel LLC , based on Form 13F filings with the SEC.

News

Stay updated on Inverness Counsel LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email